Haywood bullish on U.S. cannabis prospects in 2022

Green Thumb Industries

11/01/2022 18:59

** Haywood says it is optimistic for U.S. cannabis sector
heading into 2022 
    ** Sees strong revenue growth across sector, although at a
lower percentage compared to last year
    ** Says prospects are compelling, irrespective of any
federal reform, with addition of new markets and continued
growth in existing markets
    ** "We remain hopeful there will be progress on federal
reform, at some point, with pressure likely to mount throughout
the year with upcoming mid-terms", says Haywood
    ** Brokerage, however, warns there is a dearth of equity
capital that can be invested in the cannabis sector
    ** Haywood rates Curaleaf  CURA.CD , Trulieve  TRUL.CD  and
Green Thumb  GTII.CD  as "buy"
    ** Shares of CURA, TRUL and GTII fell 25.9%, 18.1% and 9.6%,
respectively, in 2021

 (Reporting by Vansh Agarwal)
 ((Vansh.Agarwal@thomsonreuters.com;))